In our role as global health leader, we are closely monitoring the COVID-19 (coronavirus) pandemic and taking steps to help prevent the spread of the virus as well as exploring the potential for a vaccine.
One of our most critical goals is to ensure a continued supply of our medicines to the patients who depend on them.
Restrictions imposed to help manage the spread of coronavirus is presenting global supply chains with unprecedented logistical challenges. We are working closely with suppliers, distributors, local governments and regulators to continue to meet patient needs.
We are taking all possible measures to maximize product availability.